Grants Archive - Page 159 of 180 - Kenneth Rainin Foundation

There is still no medical cure for inflammatory bowel diseases (IBD) and the clinical management is challenging. In particular, differentiating between Crohn’s disease (CD) and ulcerative colitis (UC) and predicting the clinical course or the response to therapy is difficult. In this study, we aim to characterize tissue samples from IBD and control patients with […]

Intestinal Bowel Diseases (IBD) affect millions of lives worldwide. However, therapeutic options for IBD treatment are limited. In this proposal, building upon our previous findings, we propose to examine an important protein called ARTS, which has never-before been studied in connection to IBD. We have found that ARTS is able to coordinate the cellular suicide […]

There is still no medical cure for inflammatory bowel diseases (IBD) and the clinical management is challenging. In particular, differentiating between Crohn’s disease (CD) and ulcerative colitis (UC) and predicting the clinical course or the response to therapy is difficult. In this study, we aim to characterize tissue samples from IBD and control patients with […]

Precise manipulation of diet and gut microbiota is a novel and non-invasive therapy for IBD which is of great interest to patients. Enteral nutrition provides a clear example of a dietary intervention improving clinical outcomes such as mucosal healing. However, previous studies in IBD have altered several different dietary components at once making it challenging […]

The gut microbiota is believed to play a critical role in inflammation in Crohn’s disease (CD). Adherent–invasive Escherichia coli (AIEC) often colonize the intestinal mucosa of CD patients. AIEC colonization may promote intestinal inflammation in CD patients. We have found that AIEC prefers to use the amino acid L-serine for growth in the inflamed gut. […]